CL King Initiates Coverage On ICU Medical with Buy Rating, Announces Price Target of $110
Portfolio Pulse from Benzinga Newsdesk
CL King analyst Kristen Stewart has initiated coverage on ICU Medical (NASDAQ:ICUI) with a Buy rating and set a price target of $110.
December 14, 2023 | 6:44 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
ICU Medical has been given a Buy rating and a price target of $110 by CL King analyst Kristen Stewart.
The initiation of coverage by an analyst with a Buy rating typically suggests a positive outlook on the stock's future performance. The price target of $110 indicates a potential upside from the current trading price, which could attract investor interest and drive up the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100